Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer
| Autor: | A. Rolevich, A. Minich, Tatiana Nabebina, Oleg Sukonko, Sergey L. Polyakov, Sergey Krasny |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Original Paper
medicine.medical_specialty Bladder cancer Multivariate analysis business.industry General surgery 030232 urology & nephrology General Medicine medicine.disease Recurrence risk Surgery 03 medical and health sciences 0302 clinical medicine non-muscle invasive bladder cancer 030220 oncology & carcinogenesis Statistical significance medicine Bladder tumor transurethral resection In patient Single institution Non muscle invasive business quality of surgery |
| Zdroj: | Central European Journal of Urology |
| ISSN: | 2080-4873 |
| DOI: | 10.5173/ceju.2016.795 |
| Popis: | Introduction One of the factors responsible for the risk of recurrence after complete transurethral resection of the bladder tumor (TURBT) in patients with non-muscle invasive bladder cancer (NMIBC) is the quality of surgery that may vary between individual surgeons. The aim of the study was to evaluate the impact of the surgeon on recurrence-free survival in patients with NMIBC. Material and methods The long-term results of a series of consecutive TURBTs performed by five staff urologists at a single institution were retrospectively analyzed. A total of 949 cases of organ-preserving treatment in 784 patients with NMIBC were included in the analysis. Results With the median follow-up of 64.3 months (3–124 months), the 5-year recurrence-free survival rates according to the surgeon were 62.9% (95% CI 56.2–69.7%), 53.6% (95% CI 47.4–59.9%), 51.0% (95% CI 39.6–62.4%), 46.2% (95% CI 36.4–56.0%), and 44.2% (95% CI 36.8–51.7%), respectively (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|